Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis

BACKGROUND: Newborn screening (NBS) for cystic fibrosis (CF) not only identifies infants with a diagnosis of CF, but also those with an uncertain diagnosis of cystic fibrosis (CF), i.e. CF transmembrane conductance regulator (CFTR)-related metabolic syndrome (CRMS) or CF screen positive inconclusive...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Pediatr
Autors principals: Ooi, Chee Y., Sutherland, Rosie, Castellani, Carlo, Keenan, Katherine, Boland, Margaret, Reisman, Joe, Bjornson, Candice, Chilvers, Mark A., van Wylick, Richard, Kent, Steven, Price, April, Mateos-Corral, Dimas, Hughes, Daniel, Solomon, Melinda, Zuberbuhler, Peter, Brusky, Janna, Durie, Peter R., Ratjen, Felix, Gonska, Tanja
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6805545/
https://ncbi.nlm.nih.gov/pubmed/31640630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12887-019-1756-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars